These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7507901)

  • 1. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.
    Domer JE; Human LG; Andersen GB; Rudbach JA; Asherson GL
    Infect Immun; 1993 May; 61(5):2122-30. PubMed ID: 8478102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.
    Garner RE; Childress AM; Human LG; Domer JE
    Infect Immun; 1990 Aug; 58(8):2613-20. PubMed ID: 2142482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.
    Domer JE; Garner RE; Befidi-Mengue RN
    Infect Immun; 1989 Mar; 57(3):693-700. PubMed ID: 2917780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
    Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
    Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.
    Carrow EW; Domer JE
    Infect Immun; 1985 Jul; 49(1):172-81. PubMed ID: 4008047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.
    Pietrella D; Mazzolla R; Lupo P; Pitzurra L; Gomez MJ; Cherniak R; Vecchiarelli A
    Infect Immun; 2002 Dec; 70(12):6621-7. PubMed ID: 12438334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis.
    Diez A; Arrieta-Aguirre I; Carrano G; Fernandez-de-Larrinoa I; Moragues MD
    Vaccine; 2024 Aug; 42(20):125990. PubMed ID: 38789371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
    Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
    Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans mannan-specific, delayed hypersensitivity down-regulatory CD8+ cells are genetically restricted effectors and their production requires CD4 and I-A expression.
    Li SP; Lee SI; Wang Y; Domer JE
    Int Arch Allergy Immunol; 1996 Apr; 109(4):334-43. PubMed ID: 8634517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodiagnosis of candida-infections. I. Sensitivity of the antigens.
    Tomsíková A; Sach J; Zavázal V; Masler L; Nováckova D
    Mycopathologia; 1980 Jul; 71(2):103-11. PubMed ID: 6993955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.
    Viudes A; Lazzell A; Perea S; Kirkpatrick WR; Peman J; Patterson TF; Martinez JP; López-Ribot JL
    FEMS Microbiol Lett; 2004 Mar; 232(2):133-8. PubMed ID: 15033231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice.
    Hurtrel B; Langrange PH; Michel JC
    Infect Immun; 1981 Jan; 31(1):95-101. PubMed ID: 7012009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of the anti-Candida albicans mannan immune response using synthetic oligomannosides reveals unique properties of β-1,2 mannotriose protective epitopes.
    Sendid B; Lecointe K; Collot M; Danzé PM; Damiens S; Drucbert AS; Fradin C; Vilcot JP; Grenouillet F; Dubar F; de Ruyck J; Jawhara S; Mallet JM; Poulain D
    Sci Rep; 2021 May; 11(1):10825. PubMed ID: 34031516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
    Tansho S; Ab S; Mizutani S; Ono Y; Takesako K; Yamaguchi H
    Microbiol Immunol; 2002; 46(5):307-11. PubMed ID: 12139389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.